Brand name – Xbira
Generic name – Abiraterone Acetate
Salt composition – Abiraterone Acetate 250 mg
Manufacturer – Cipla
Dosage form – Oral (tablet)
Packaging – Bottle
Indication – Prostate cancer
Strength – 250 mg
Gender – Males
Prescription required – Yes
Description
Xbira (Abiraterone Acetate) tablet is used in men to treat the cancer of the prostate
gland. It is not known if Xbira is safe for use in women or children. This medicine should
not be taken on an empty stomach.
Pharmacodynamics
Abiraterone acetate (Zytiga) is converted in vivo to abiraterone, which is an androgen
biosynthesis inhibitor. It inhibits 17α-hydroxylase/C17,20-lyase (CYP17). This enzyme is
expressed in testicular, adrenal, and prostatic tumor tissues. It is required for androgen
biosynthesis.
Alternate Brands
- Abiracine
- Abirakast
- Abirapro
Side Effects
● Confusion
● Sweating
● Irritability
● Joint pain
● Nausea
● Headache
● Swelling in legs
● Fast heartbeat
● Diarrhea
● High blood pressure
● Fever
● Dizziness
● Muscle pain
● Headache
● Weakness
Dosage
Normal Dose
Take the Xbira tablet exactly as your healthcare provider tells you. Do not alter or
increase the dose strength on your own, unless your healthcare provider tells you.
Missed Dose
In case of the missed dose, make sure to first contact your healthcare provider. Do not
double the dose to catch up.
Overdose
Seek immediate medical help.
Usage Of Medicine
Xbira (Abiraterone Acetate) 250 mg tablet is used in the treatment of prostate cancer.
The active ingredient of Xbira is Abiraterone Acetate.
Warning And Precautions
● Do not crush, chew or break the tablet.
● Tell your healthcare provider beforehand, if you have heart, kidney, or any serious
problem. Also, make sure to tell your heathcare provider about your medical
history and medical condition, along with the medicines you already take.
● It is not known if this medicine is safe for use in women.
● Avoid driving or operating heavy machines, in case you feel unwell.
Contraindications
Do not administer this tablet to those patients who have a known allergy to any of the
ingredients of this tablet.
